Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| American Bitcoin Corp.KERN · Entity 5010 | Director | April 25, 2022 | April 27, 2022 |
| Medicus Pharma Ltd.MDCX · Entity 7770 | Director | June 03, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
American Bitcoin Corp.
Report date April 25, 2022 · Filed April 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 6,132 |
Reported balance
After 2022-04-25 transaction · row 1
1 source rowRow 1 · 2022-04-25 · Exercise / conversion · Acquired 3,486 · Balance 6,132 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs were awarded on January 25, 2022 and vest as follows: 3,486 on March 31, 2022; 3,486 on June 30, 2022; 3,486 on September 30, 2022; and 3,486 on December 31, 2022. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2022-12-31 | Direct | 10,458 |
Reported balance
After 2022-04-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-04-25 · Exercise / conversion · Disposed 3,486 · Balance 10,458 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs were awarded on January 25, 2022 and vest as follows: 3,486 on March 31, 2022; 3,486 on June 30, 2022; 3,486 on September 30, 2022; and 3,486 on December 31, 2022. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs were awarded on January 25, 2022 and vest as follows: 3,486 on March 31, 2022; 3,486 on June 30, 2022; 3,486 on September 30, 2022; and 3,486 on December 31, 2022. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date.
Medicus Pharma Ltd.
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.36 · Expires 2031-06-03 | Direct | 50,000 |
Reported balance
After 2026-06-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-03 · Grant · Acquired 50,000 · Balance 50,000 F1: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. |
Filing footnotes · ownership attribution and instrument terms
F1: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 4, 2026 20:09 UTC | Medicus Pharma Ltd. MDCX · Entity 7770 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950142-26-001636 · es260786888_4-fishman.xml · derivative · entry 1 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2031-06-03 F1 · derivative.exercise_date: The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 23:11 UTC | Medicus Pharma Ltd. MDCX · Entity 7770 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950142-26-001026 · es260758765_4-fishman.xml · derivative · entry 1 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2031-03-27 Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:08 UTC | Medicus Pharma Ltd. MDCX · Entity 7770 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000950142-25-003234 · es250717263_4-fishman.xml · derivative · entry 1 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 21:14 UTC | Medicus Pharma Ltd. MDCX · Entity 7770 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.08 | $0.00 |
DisclosureSEC source: 0000950142-25-002015 · es250658440_4-fishman.xml · derivative · entry 2 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires 2030-07-22 F3 · derivative.exercise_date: The option was granted on July 22, 2025. The option is scheduled to vest quarterly in four equal installments over one year. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 19:16 UTC | American Bitcoin Corp. KERN · Entity 5010 | Exercise / conversionRestricted Stock Units · Derivative | 3,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-009018 · doc1.xml · derivative · entry 2 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,458 Underlying: Common Shares · 3,486 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs were awarded on January 25, 2022 and vest as follows: 3,486 on March 31, 2022; 3,486 on June 30, 2022; 3,486 on September 30, 2022; and 3,486 on December 31, 2022. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs were awarded on January 25, 2022 and vest as follows: 3,486 on March 31, 2022; 3,486 on June 30, 2022; 3,486 on September 30, 2022; and 3,486 on December 31, 2022. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 19:16 UTC | American Bitcoin Corp. KERN · Entity 5010 | Exercise / conversionCommon Shares | 3,486 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-22-009018 · doc1.xml · nonDerivative · entry 1 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs were awarded on January 25, 2022 and vest as follows: 3,486 on March 31, 2022; 3,486 on June 30, 2022; 3,486 on September 30, 2022; and 3,486 on December 31, 2022. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. Read SEC document |
| January 25, 2022 Filed Feb 1, 2022 02:00 UTC | American Bitcoin Corp. KERN · Entity 5010 | GrantRestricted Stock Units · Derivative | 13,944 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-002092 · doc1.xml · derivative · entry 1 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,944 Underlying: Common Shares · 13,944 shares Expires 2022-12-31 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest as follows: 3,486 on March 31, 2022; 3,486 on June 30, 2022; 3,486 on September 30, 2022; and 3,486 on December 31, 2022. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest as follows: 3,486 on March 31, 2022; 3,486 on June 30, 2022; 3,486 on September 30, 2022; and 3,486 on December 31, 2022. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. Read SEC document |
| December 21, 2021 Filed Jan 11, 2022 15:59 UTC | American Bitcoin Corp. KERN · Entity 5010 | Exercise / conversionRestricted Stock Units · Derivative | 2,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-000979 · doc1.xml · derivative · entry 5 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("RSU"). The RSUs shall vest as follows: 308 on 6/30/2021; 1,169 on September 30, 2021; and 1,169 on December 31, 2021. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("RSU"). The RSUs shall vest as follows: 308 on 6/30/2021; 1,169 on September 30, 2021; and 1,169 on December 31, 2021. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("RSU"). The RSUs shall vest as follows: 308 on 6/30/2021; 1,169 on September 30, 2021; and 1,169 on December 31, 2021. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. Read SEC document |
| December 21, 2021 Filed Jan 11, 2022 15:59 UTC | American Bitcoin Corp. KERN · Entity 5010 | Exercise / conversionCommon Shares | 2,338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-22-000979 · doc1.xml · nonDerivative · entry 2 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("RSU"). The RSUs shall vest as follows: 308 on 6/30/2021; 1,169 on September 30, 2021; and 1,169 on December 31, 2021. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. Read SEC document |
| August 04, 2021 Filed Jan 11, 2022 15:59 UTC | American Bitcoin Corp. KERN · Entity 5010 | Exercise / conversionRestricted Stock Units · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-000979 · doc1.xml · derivative · entry 4 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,338 Underlying: Common Shares · 308 shares Expires 2022-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("RSU"). The RSUs shall vest as follows: 308 on 6/30/2021; 1,169 on September 30, 2021; and 1,169 on December 31, 2021. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("RSU"). The RSUs shall vest as follows: 308 on 6/30/2021; 1,169 on September 30, 2021; and 1,169 on December 31, 2021. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. Read SEC document |
| August 04, 2021 Filed Jan 11, 2022 15:59 UTC | American Bitcoin Corp. KERN · Entity 5010 | Exercise / conversionCommon Shares | 308 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-22-000979 · doc1.xml · nonDerivative · entry 1 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("RSU"). The RSUs shall vest as follows: 308 on 6/30/2021; 1,169 on September 30, 2021; and 1,169 on December 31, 2021. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. Read SEC document |
| June 10, 2021 Filed Jan 11, 2022 15:59 UTC | American Bitcoin Corp. KERN · Entity 5010 | GrantRestricted Stock Units · Derivative | 2,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-000979 · doc1.xml · derivative · entry 3 FISHMAN BARRY · CIK 0001889532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,646 Underlying: Common Shares · 2,646 shares Expires 2022-01-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("RSU"). The RSUs shall vest as follows: 308 on 6/30/2021; 1,169 on September 30, 2021; and 1,169 on December 31, 2021. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("RSU"). The RSUs shall vest as follows: 308 on 6/30/2021; 1,169 on September 30, 2021; and 1,169 on December 31, 2021. Settlement of vested RSUs will occur as soon as administratively feasible following the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.